Press release
Chronic Inflammatory Demyelinating Polyneuropathy Pipeline Therapeutics Assessment Report 2024 (Updated)
Chronic Inflammatory Demyelinating Polyneuropathy Pipeline
Explore our latest breakthroughs in Chronic Inflammatory Demyelinating Polyneuropathy Research. Learn more about our innovative pipeline today! @ Chronic Inflammatory Demyelinating Polyneuropathy Pipeline Outlook- https://www.delveinsight.com/sample-request/chronic-inflammatory-demyelinating-polyneuropathy-cidp-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Chronic Inflammatory Demyelinating Polyneuropathy Pipeline Report
• In December 2024:- Janssen Research & Development LLC- The main purpose of this study is to evaluate the safety and efficacy of nipocalimab compared to placebo in delaying relapse in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) who initially respond to nipocalimab in Stage A.
• In December 2024:- CSL Behring- A randomized, open-label, prospective, multicenter study designed to investigate 2 dose levels in pediatric subjects 2 to ≤ 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment
• DelveInsight's Chronic Inflammatory Demyelinating Polyneuropathy pipeline report depicts a robust space with 8+ active players working to develop 10+ pipeline therapies for Chronic Inflammatory Demyelinating Polyneuropathy treatment.
• The leading Chronic Inflammatory Demyelinating Polyneuropathy Companies such as Takeda, Sanofi, Johnson & Johnson Services, Immunovant, UCB S.A., GeNeuro, Nanjing IASO Biotherapeutics, Bioasis Technologies Inc., and others.
• Promising Chronic Inflammatory Demyelinating Polyneuropathy Therapies such as Riliprubart, Batoclimab 680 mg, SAR445088, Panzyga, Efgartigimod PH20 SC, Nipocalimab, IgPro10, Immunoadsorption, TAK-771, and others.
Stay informed about the cutting-edge advancements in Chronic Inflammatory Demyelinating Polyneuropathy Treatments. Download for updates and be a part of the revolution in inflammatory disease care @ Chronic Inflammatory Demyelinating Polyneuropathy Clinical Trials Assessment- https://www.delveinsight.com/sample-request/chronic-inflammatory-demyelinating-polyneuropathy-cidp-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Chronic Inflammatory Demyelinating Polyneuropathy Emerging Drugs Profile
• Rozanolixizumab: UCB
Rozanolixizumab is a subcutaneously administered, humanized monoclonal antibody that specifically binds, with high affinity, to the human neonatal Fc receptor (FcRn). It has been designed to block the interaction of FcRn and Immunoglobulin G (IgG), accelerating the catabolism of antibodies and reducing the concentration of pathogenic IgG autoantibodies. The drug is under clinical development with the aim of improving the lives of people with pathogenic IgG-autoantibody-driven autoimmune diseases, including ITP, myasthenia gravis (MG), and CIDP, by driving the removal of pathogenic IgG autoantibodies. Currently, the drug is in the Phase II stage of its development for the treatment of CIDP.
• Temelimab: GeNeuro SA
Temelimab is a monoclonal antibody designed to neutralize a pathogenic viral envelope protein, encoded by a member of the Human Endogenous Retrovirus-W family, pHERV-W. This protein is thought to be a causal factor in several diseases, including multiple sclerosis, Type 1 diabetes and CIDP. It neutralizes the pHERV-W Env protein without targeting the patient's immune system, and could be a treatment that is both safe and effective in slowing or stopping the disease's progress in all its forms. By neutralizing pHERV-W env, GNbAC1 could at the same time block these pathological inflammatory processes and restore remyelination in patients. The drug is currently in Phase I trial for the treatment of CIDP patients.
Learn more about Chronic Inflammatory Demyelinating Polyneuropathy Drugs opportunities in our groundbreaking Chronic Inflammatory Demyelinating Polyneuropathy Research and development projects @ Chronic Inflammatory Demyelinating Polyneuropathy Unmet Needs- https://www.delveinsight.com/sample-request/chronic-inflammatory-demyelinating-polyneuropathy-cidp-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Chronic Inflammatory Demyelinating Polyneuropathy Companies
Takeda, Sanofi, Johnson & Johnson Services, Immunovant, UCB S.A., GeNeuro, Nanjing IASO Biotherapeutics, Bioasis Technologies Inc., and others.
Chronic Inflammatory Demyelinating Polyneuropathy pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
• Intravenous
• Subcutaneous
• Oral
• Intramuscular
Chronic Inflammatory Demyelinating Polyneuropathy Products have been categorized under various Molecule types such as
• Monoclonal antibody
• Small molecule
• Peptide
Discover the latest advancements in Chronic Inflammatory Demyelinating Polyneuropathy Treatment by visiting our website. Stay informed about how we're transforming the future of Neurology @ Chronic Inflammatory Demyelinating Polyneuropathy Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/chronic-inflammatory-demyelinating-polyneuropathy-cidp-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Chronic Inflammatory Demyelinating Polyneuropathy Pipeline Report
• Coverage- Global
• Chronic Inflammatory Demyelinating Polyneuropathy Companies- Takeda, Sanofi, Johnson & Johnson Services, Immunovant, UCB S.A., GeNeuro, Nanjing IASO Biotherapeutics, Bioasis Technologies Inc., and others.
• Chronic Inflammatory Demyelinating Polyneuropathy Therapies- Riliprubart, Batoclimab 680 mg, SAR445088, Panzyga, Efgartigimod PH20 SC, Nipocalimab, IgPro10, Immunoadsorption, TAK-771, and others.
• Chronic Inflammatory Demyelinating Polyneuropathy Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Chronic Inflammatory Demyelinating Polyneuropathy Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
For a detailed overview of our latest research findings and future plans, read the full details of Chronic Inflammatory Demyelinating Polyneuropathy Pipeline on our website @ Chronic Inflammatory Demyelinating Polyneuropathy Drugs and Companies- https://www.delveinsight.com/sample-request/chronic-inflammatory-demyelinating-polyneuropathy-cidp-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Chronic Inflammatory Demyelinating Polyneuropathy: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Chronic Inflammatory Demyelinating Polyneuropathy- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Product Name: Company Name
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Rozanolixizumab: UCB S.A.
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. Temelimab: GeNeuro SA
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name: Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Chronic Inflammatory Demyelinating Polyneuropathy Key Companies
21. Chronic Inflammatory Demyelinating Polyneuropathy Key Products
22. Chronic Inflammatory Demyelinating Polyneuropathy- Unmet Needs
23. Chronic Inflammatory Demyelinating Polyneuropathy- Market Drivers and Barriers
24. Chronic Inflammatory Demyelinating Polyneuropathy- Future Perspectives and Conclusion
25. Chronic Inflammatory Demyelinating Polyneuropathy Analyst Views
26. Chronic Inflammatory Demyelinating Polyneuropathy Key Companies
27. Appendix
List of the Top Selling Market Research Reports in 2024
Celiac Disease Market: https://www.delveinsight.com/report-store/celiac-disease-cd-market
Coronary Stents Market: https://www.delveinsight.com/report-store/coronary-stents-market-market
CXCR Inhibitors Market: https://www.delveinsight.com/report-store/selective-inhibitor-of-the-cxcr4-chemokine-receptor-market-forecast
Diabetic Gastroparesis Market: https://www.delveinsight.com/report-store/gastroparesis-market
Fertility Monitoring Devices Market: https://www.delveinsight.com/report-store/fertility-monitoring-devices-fertility-testing-devices-market
Phototherapies for Psoriasis Market: https://www.delveinsight.com/report-store/phototherapies-for-psoriasis-market
Pipeline Assessment Services: https://www.delveinsight.com/consulting/pipeline-assessment-services
Ranibizumab Biosimilars Market: https://www.delveinsight.com/report-store/ranibizumab-biosimilars-insight
Rhinitis Market: https://www.delveinsight.com/report-store/rhinitis-market
Skin Grafting Devices Market: https://www.delveinsight.com/report-store/skin-grafting-devices-market
Spinal Implants Market: https://www.delveinsight.com/report-store/spinal-implants-market
Surgical Sealant Market: https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Thrombectomy Devices Market: https://www.delveinsight.com/report-store/thrombectomy-devices-market
Venous Ulcer Market: https://www.delveinsight.com/report-store/venous-leg-ulcer-market
ADHD Market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Bacterial Meningitis Market: https://www.delveinsight.com/report-store/meningococcal-meningitis-market
Heart Pump Devices Market: https://www.delveinsight.com/report-store/heart-pump-device-market
Meningococcal Meningitis Market: https://www.delveinsight.com/report-store/meningococcal-meningitis-market
Percutaneous Arterial Closure Device Market: https://www.delveinsight.com/report-store/vascular-closure-devices-market
Pouchitis Market: https://www.delveinsight.com/report-store/pouchitis-market
Respiratory Syncytial Virus Market: https://www.delveinsight.com/report-store/respiratory-syncytial-virus-rsv-market
Shingles Market: https://www.delveinsight.com/report-store/shingles-market
Artificial Disc Market: https://www.delveinsight.com/report-store/artificial-disc-market
Avascular Necrosis Market: https://www.delveinsight.com/report-store/avascular-necrosis-market
Embolotherapy Market: https://www.delveinsight.com/report-store/embolotherapy-market
Orthopedic Power Devices Market: https://www.delveinsight.com/report-store/orthopedic-power-devices-market
Perennial Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
Plaque Psoriasis Market: https://www.delveinsight.com/report-store/plaque-psoriasis-market
Psoriasis Vulgaris Market: https://www.delveinsight.com/report-store/psoriasis-vulgaris-market
Transcatheter Heart Valve Replacement Devices Market: https://www.delveinsight.com/report-store/transcatheter-aortic-valve-replacement-market
UK Healthcare Report: https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
Attention Deficit Hyperactivity Disorder Market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Brucellosis Market: https://www.delveinsight.com/report-store/brucellosis-market
Coronary Angioplasty Market: https://www.delveinsight.com/report-store/coronary-stents-market-market
NK Cell Therapy Market: https://www.delveinsight.com/report-store/nk-cell-therapy-market
Scoliosis Market: https://www.delveinsight.com/report-store/scoliosis-market
Surgical Site Infections Market: https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market
Attention Deficit Hyperactivity Disorder ADHD Market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Catheter Stabilization Devices Market: https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market
Diabetic Wound Market: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
Dyspepsia Market: https://www.delveinsight.com/report-store/functional-dyspepsia-market-share
Indwelling Catheters Market: https://www.delveinsight.com/report-store/indwelling-catheters-market
Orthopedic Splints Device Market: https://www.delveinsight.com/report-store/orthopedic-splints-market
Sepsis Market: https://www.delveinsight.com/report-store/sepsis-market
Overactive Bladder Syndrome Market: https://www.delveinsight.com/report-store/overactive-bladder-market
Spinal Trauma Devices Market: https://www.delveinsight.com/report-store/spinal-trauma-devices-market-market
Temporomandibular Disorders Market: https://www.delveinsight.com/report-store/temporomandibular-disorders-market
Viscosupplementation Devices Market: https://www.delveinsight.com/report-store/viscosupplementation-devices-market
Vitreoretinal Surgery Devices Market: https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Advanced Liver Cancer Market: https://www.delveinsight.com/report-store/liver-cancer-market
Gene Therapy in CNS Disorder Market: https://www.delveinsight.com/report-store/gene-therapy-in-cns-disorder-market
Lice Infestations Market: https://www.delveinsight.com/report-store/lice-infestations-market
Plantar Fasciitis Market: https://www.delveinsight.com/report-store/plantar-fasciitis-market
Biopsy Devices Market: https://www.delveinsight.com/report-store/biopsy-devices-market
Endoscopic Ultrasound Market: https://www.delveinsight.com/report-store/endoscopic-ultrasound-market
Healthcare Consulting Solutions: https://www.delveinsight.com/consulting
Pelvic Organ Prolapse Market: https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
Pulmonary Emphysema Market: https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market
Schistosomiasis Market: https://www.delveinsight.com/report-store/schistosomiasis-market
Testicular Neoplasm Market: https://www.delveinsight.com/report-store/testicular-neoplasm-market
Tourette Syndrome Market: https://www.delveinsight.com/report-store/tourette-syndrome-market
Wound Healing Devices Market: https://www.delveinsight.com/report-store/wound-healing-devices-market
Chronic Neuropathic Pain Market: https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
Fabry Disease Market: https://www.delveinsight.com/report-store/fabry-disease-market
Transcatheter Treatment Market: https://www.delveinsight.com/report-store/transcatheter-treatment-market
SGLT2 Inhibitors Market: https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Surgical Lasers Market: https://www.delveinsight.com/report-store/surgical-lasers-market
Stem Cell Market: https://www.delveinsight.com/report-store/stem-cell-market
Myeloproliferative Neoplasms Market: https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
Pacemakers Market: https://www.delveinsight.com/report-store/pacemakers-market
Urea Cycle Disorders Market: https://www.delveinsight.com/blog/urea-cycle-disorder-market
Varicose Vein Treatment Devices Market: https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulator Market: https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Intraocular Lens Market: https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Lymphoedema Market: https://www.delveinsight.com/report-store/lymphedema-market
Somatotropin Deficiency Market: https://www.delveinsight.com/report-store/somatotropin-deficiency-market
Skin Neoplasm Market: https://www.delveinsight.com/report-store/nonmelanoma-skin-cancer-market
Antibody Drug Conjugate Market: https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
Surgical Mask & Respirator Market: https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Meibomian Gland Dysfunction Market: https://www.delveinsight.com/report-store/meibomian-gland-dysfunction-pipeline-insight
Novel Drug Delivery Devices Market: https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Total Knee Arthroplasty Market: https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Asperger Syndrome Market: https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market
Medical Marijuana Market: https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Lactose Intolerance Market: https://www.delveinsight.com/report-store/lactose-intolerance-market
Microscopy Device Market: https://www.delveinsight.com/sample-request/microscopy-device-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Inflammatory Demyelinating Polyneuropathy Pipeline Therapeutics Assessment Report 2024 (Updated) here
News-ID: 3778965 • Views: …
More Releases from DelveInsight Business Research LLP
Dihydroorotate Dehydrogenase (DHODH) Inhibitors Market Expected to Witness Signi …
The Dihydroorotate Dehydrogenase (DHODH) Inhibitors market is expected to experience robust growth during the forecast period (2022-2036), supported by increasing clinical interest in DHODH-targeted therapies across multiple therapeutic areas, including autoimmune disorders, hematological malignancies, solid tumors, and viral infections. The growing pipeline of next-generation DHODH inhibitors, coupled with expanding research into their immunomodulatory and anti-proliferative mechanisms, is anticipated to transform the competitive landscape over the coming decade.
DelveInsight's "Dihydroorotate Dehydrogenase (DHODH)…
Non-tuberculous Mycobacterial (NTM) Infections Market Expected to Witness Signif …
The Non-tuberculous Mycobacterial (NTM) Infections market is anticipated to witness substantial growth across the seven major markets (7MM) during the forecast period (2022-2036), driven by increasing disease prevalence, improved diagnostic capabilities, greater clinical awareness, and the development of innovative therapies targeting difficult-to-treat NTM infections. With pipeline candidates such as Epetraborole and NUZYRA (omadacycline) advancing through clinical development, the treatment landscape is expected to evolve significantly over the coming decade.
DelveInsight's "Non-tuberculous…
Niemann-Pick Disease Type C (NPC) Market Expected to Witness Robust Growth Throu …
The Niemann-Pick Disease Type C (NPC) market is projected to witness substantial growth across the seven major markets (7MM) during the forecast period (2022-2036), supported by increasing disease awareness, advances in genetic and biomarker-based diagnosis, and the emergence of innovative disease-modifying therapies. The treatment landscape is evolving rapidly with therapies such as TRAPPSOL CYCLO, Nizubaglustat, AQNEURSA, and MIPLYFFA, which are expected to significantly improve clinical outcomes for patients with this…
PD-1 and PD-L1 Inhibitors Market Size to Reach USD 84.4 Billion by 2034 at a CAG …
The PD-1 and PD-L1 Inhibitors market is estimated at USD 56.8 billion in 2025 and is projected to reach USD 84.4 billion by 2034. Growth is anchored in checkpoint blockade's entrenched position as first-line standard of care across solid tumors, its migration into perioperative and adjuvant use, and the rise of PD-1/PD-L1 bispecific antibodies, tempered by the 2028 loss of pembrolizumab's exclusivity.
DelveInsight's PD-1 and PD-L1 Inhibitors Market Insights Report 2034…
More Releases for Market:
Malaysia Data Center Market Report, Market Major Players, Market Statistics, Mar …
Malaysia Will Be Home to More Than 200 Mw Of Data Center Capacity By 2029
Malaysia has become a connectivity hub of Southeast Asia, with nearly 23 undersea cable systems linking the nation to global networks. The Malaysia data center market is also witnessing new trends every day, making it one of the fastest-growing in the Asia Pacific region, with expanding digital consumers in the region while the demand for IoT,…
UAE Hot Beverages Market Report, Market Size, Market Share, Market Revenue, Mark …
The UAE hot beverage market is rapidly expanding, driven by premiumization, evolving consumer preferences, and digitization. The market is dominated by coffee segment which contributes to 60% of total hot beverage sales in 2024. The hospitality and food service sector play a crucial role in market, with coffee shops generating more than USD 3 million revenue aa of early 2025. E-commerce and online platforms are reshaping the hot beverage sales…
Syringe and Needle Market Size, Market Share, Market Trends, Market Analysis, Ma …
Market Overview:
The global syringe and needle market is a critical component of the healthcare industry, serving as indispensable tools for administering medications, vaccines, and drawing blood samples. This market is characterized by a diverse range of products catering to various medical needs, including disposable syringes, safety syringes, insulin syringes, hypodermic needles, and more. This article provides an in-depth analysis of the syringe and needle market, focusing on its market overview,…
India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned?
In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth…
Robotic Cardiology Surgery Market Insights Includes Market Share, Market Researc …
Robotic Cardiology Surgery Market
Global demand for cardiac surgery robots in 2025 will explode to $XXX billion. This represents an astonishing XX% growth yearly in terms of annual revenue between 2016 and 2025, and a cumulative market total of $7.50 billion during 2017-2025 owing to the substantial increase of robot-based and computer-assisted cardiological surgery procedures for heart disorders.
Global Robotic Cardiology Surgery Market 2016-2025: Market Size, Share, Forecast and Strategy is based…
Ethanol Market: Market Intelligence and Market Trends
Ethanol is a compound which is manufactured by the fermentation of various biological materials such as wheat, corn, wood, barley and sugarcane. Corn and starch based crops are the most common materials used in ethanol production. This compound is miscible with water and most of the organic solvent.
Ethanol is a very important element of various industries and used as a solvent for many substances. It is because of wide range…
